Abstract:In recent years, the application of advanced analytics, especially artificial intelligence (AI), to digital H&E images, and other histological image types, has begun to radically change how histological images are used in the clinic. Alongside the recognition that the tumour microenvironment (TME) has a profound impact on tumour phenotype, the technical development of highly multiplexed immunofluorescence platforms has enhanced the biological complexity that can be captured in the TME with high precision. AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important outcomes, as occurs in distinct stages in conventional machine learning. Deep-learning algorithms are able to elucidate TME patterns inherent in the input data with minimum levels of human intelligence and, hence, have the potential to achieve clinically relevant predictions and discovery of important TME features. Furthermore, the diverse repertoire of deep-learning algorithms able to interrogate TME patterns extends beyond convolutional neural networks to include attention-based models, graph neural networks, and multimodal models. To date, AI models have largely been evaluated retrospectively, outside the well-established rigour of prospective clinical trials, in part because traditional clinical trial methodology may not always be suitable for the assessment of AI technology. However, to enable digital pathology-based advanced analytics to meaningfully impact clinical care, specific measures of 'added benefit' to the current standard of care and validation in a prospective setting are important. This will need to be accompanied by adequate measures of explainability and interpretability. Despite such challenges, the combination of expanding datasets, increased computational power, and the possibility of integration of pre-clinical experimental insights into model development means there is exciting potential for the future progress of these AI applications. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Towards next-generation diagnostic pathology: AI-empowered label-free multiphoton microscopy

Analysis of Intraoperative Microscopy Imaging Techniques and Their Future Applications

Multi-modality artificial intelligence in digital pathology

AI Empowered of Advancements in Microbial and Tumor Cell Image Labeling for Enhanced Medical Insights

Application of Multiphoton Microscopy in Disease Diagnosis

Label-free Multiphoton Microscopy for Ex Vivo Brain Imaging: Toward Assisting Pathologic Diagnosis

Multiplex Imaging Analysis in Pathology: a Comprehensive Review on Analytical Approaches and Digital Toolkits

Pathogenomics for accurate diagnosis, treatment, prognosis of oncology: a cutting edge overview

Emerging role of deep learning-based artificial intelligence in tumor pathology

Advances in Digital Pathology: From Artificial Intelligence to Label-Free Imaging

Current Landscape of Advanced Imaging Tools for Pathology Diagnostics

Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Artificial intelligence in diagnostic pathology

Optical histopathology based on the nonlabeling analysis with multiphoton excitation imaging

Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling

Artificial Intelligence for Digital and Computational Pathology

Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response

Artificial Intelligence and Its Applications in Digital Hematopathology

Progress of Machine Vision in the Detection of Cancer Cells in Histopathology.

Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond